MDM2, MDMX and p53 in oncogenesis and cancer therapy

Cited by (998)

Items 801–900 of 998

1. Effect of Antibiotic Amphotericin B Combinations with Selected 1,3,4-Thiadiazole Derivatives on RPTECs in an In Vitro Model
   Agnieszka Dróźdż, Adrianna Sławińska-Brych, Dominika Kubera, Magdalena Kimsa‐Dudek, Joanna Magdalena Gola, Jolanta Adamska, Celina Kruszniewska‐Rajs, Arkadiusz Paweł Matwijczuk, Dariusz Karcz, Wojciech Dąbrowski et al. · 2022 · International Journal of Molecular Sciences
2. Intersections of Ubiquitin-Proteosome System and Autophagy in Promoting Growth of Glioblastoma Multiforme: Challenges and Opportunities
   Rhett Visintin, Swapan K. Ray · 2022 · Cells
3. An integrated investigation of structural and pathway alteration caused by PIK3CA and TP53 mutations identified in cfDNA of metastatic breast cancer
   Hephzibah Cathryn R, S. Udhaya Kumar, Gnanasambandan Ramanathan, P. Jeyaprakash Naayanan, P. Sathiyarajeswaren, M. S. Shree Devi, Satish Srinivas K., C. George Priya Doss · 2022 · Journal of Cellular Biochemistry
4. MDM4 amplification in atypical lipomatous tumors/well‐differentiated liposarcoma: Private event or alternative oncogenic mechanism?
   Nadège Gruel, Sophie El Zein, Dimitri Tzanis, Nayla Nicolas, Aurélien Maraval, Christelle Fieffe, Sylvie Bonvalot, Martial Caly, Laetitia Fuhrmann, Khadija Aït Raïs et al. · 2023 · Genes Chromosomes and Cancer
5. TP53 Alterations in Myelodysplastic Syndromes and Acute Myeloid Leukemia
   Ramy Rahmé, Thorsten Braun, James J. Manfredi, Pierre Fenaux · 2023 · Biomedicines
6. Combining intracellular antibodies to restore function of mutated p53 in cancer
   Grace Chan, Gwen Jordaan, Robert N. Nishimura, Richard H. Weisbart · 2015 · International Journal of Cancer
7. Mdm2 SNP309 G-Variant Is Associated with Invasive Growth of Human Urinary Bladder Cancer
   Florian Hitzenbichler, Robert Stoehr, Michael Rogenhofer, Wolf Ferdinand Wieland, Petra Ruemmele, Arndt Hartmann, Robert Stoehr · 2013 · Pathobiology
8. Construction and characterization of gelonin and saporin plasmids for toxic gene-based cancer therapy
   Kyoung Ah Min, Huining He, Victor Chi-Min Yang, Meong Cheol Shin · 2016 · Archives of Pharmacal Research
9. Profiling of LINE-1-Related Genes in Hepatocellular Carcinoma
   Tomoyuki Honda, Md Arifur Rahman · 2019 · International Journal of Molecular Sciences
10. LNX1 contributes to tumor growth by down‐regulating p53 stability
    Rackhyun Park, Hyun‐Ju Kim, Minsu Jang, Daum Jo, Yea–In Park, Sim Namkoong, Jin Il Lee, Ik‐Soon Jang, Junsoo Park · 2019 · The FASEB Journal
11. Anticancer Activity of Electron‐Deficient Metal Complexes against Colorectal Cancer in vitro Models
    Maria Azmanova, Joan J. Soldevila‐Barreda, Hira Bani Hani, Rianne M. Lord, Anaïs Pitto‐Barry, Steven M. Picksley, Nicolas P. E. Barry · 2019 · ChemMedChem
12. Emerging drugs for the treatment of myelofibrosis: phase II & III clinical trials
    Douglas A. Tremblay, Ronald Hoffman · 2021 · Expert Opinion on Emerging Drugs
13. Genomic Landscape of Squamous Cell Carcinoma of the Lung
    Daniel Morgensztern, Siddhartha H. K. Devarakonda, Ramaswamy Govindan · 2013 · American Society of Clinical Oncology Educational Book
14. Genomics of Immunotherapy-Associated Hyperprogressors—Response
    Shumei Kato, Razelle Kurzrock · 2017 · Clinical Cancer Research
15. The Research Progress of Metformin Regulation of Metabolic Reprogramming in Malignant Tumors
    Qihai Sui, Huiqiang Yang, Zhengyang Hu, Xing Jin, Zhencong Chen, Wei Jiang, Fenghao Sun · 2024 · Pharmaceutical Research
16. Uncovering immune cell-associated genes in breast cancer: based on summary data-based Mendelian randomized analysis and colocalization study
    Jingyang Liu, Wen Juan Sun, Ning Li, Haibin Li, Lijuan Wu, Yi Huan, Jianguang Ji, Deqiang Zheng · 2024 · Breast Cancer Research
17. Targeting p53 activation: Recent therapeutic advances in cancer and diabetic macular edema
    Zhiyi Wang, Shijie Zhang, Irakoze Loïca Mélita, Yujun Zhao · 2025 · European Journal of Medicinal Chemistry
18. Targeting the ubiquitin–proteasome system and drug therapy in colorectal cancer
    Rui Su, Yingying Shao, Qian Wang, Donghui Liu, Yitong Wang, Dexin Kong, Yuling Qiu · 2025 · Journal of Molecular Cell Biology
19. Perspectives of gene combinations in phenotype presentation
    Shihori Tanabe · 2013 · World Journal of Stem Cells
20. Apoptotic effect of chromanone derivative, hyrtiosone A from marine demosponge Hyrtios erectus in hepatocellular carcinoma HepG2 cells
    Kajal Chakraborty, Prima Francis · 2021 · Bioorganic Chemistry
21. Ribonucleotide reductase holoenzyme inhibitor COH29 interacts with deubiquitinase ubiquitin‐specific protease 2 and downregulates its substrate protein cyclin D1
    Mengying Zhu, Hui Wang, Yiluan Ding, Yuanyuan Yang, Zhuo Xu, Shi Li, Naixia Zhang · 2022 · The FASEB Journal
22. In silico RNA isoform screening to identify potential cancer driver exons with therapeutic applications
    Miquel Anglada-Girotto, Ludovica Ciampi, S. Bonnal, Sarah A. Head, Samuel Miravet-Verde, Luis Serrano · 2024 · Nature Communications
23. Autoantibody Response to Murine Double Minute 2 Protein in Immunodiagnosis of Hepatocellular Carcinoma
    Mei Liu, Su-Jun Zheng, Yú Chen, Ning Li, Peng-fei Ren, Li-Ping Dai, Zhong-Ping Duan, Jian-Ying Zhang · 2014 · Journal of Immunology Research
24. Molecular design and validation of halogen bonding orthogonal to hydrogen bonding in breast cancer MDM2–peptide complex
    Anzhong Huang, Liang Yi Zhou, Dawei Zhang, Junliang Yao, Yong Zhang · 2016 · Journal of Molecular Graphics and Modelling
25. A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors
    Rong Chen, Jingjing Zhou, Lingyun Qin, Yao Chen, Yongqi Huang, Huili Liu, Zhengding Su · 2017 · Biochemistry
26. New Antitumoral Pharmacological Strategies Involving Ca2+/Camp Signaling Pathways
    Paolo Ruggero Errante, Francisco Sandro Menezes-Rodrigues, Alberto Andrade Leite, Afonso Caricati‐Neto, † Le, ro Bueno Bergantin · 2017 · Journal of cancer epidemiology & prevention
27. Gene expression profile analysis of colon cancer grade II into grade III transition by using system biology.
    Mohammad Rostami‐Nejad, Sina Rezaei Tavirani, Vahid Mansouri, Somayeh Jahani‐Sherafat, Hamideh Moravvej Farshi · 2019 · Gastroenterology and hepatology from bed to bench.
28. Discovery of the oncogenic MDM2, a direct binding target of berberine and a potential therapeutic, in multiple myeloma
    Chuting Li, Rui Su, Xiuyuan Wang, Guiping Huang, Yanjun Liu, Juhua Yang, Zhao Yin, Chunming Gu, Jia Fei · 2022 · Functional & Integrative Genomics
29. p53-mediated metabolic response to low doses of ionizing radiation
    Isha Nagpal, Zhi-Min Yuan · 2022 · International Journal of Radiation Biology
30. Metabolism-Guided Optimization of Tryptophanol-Derived Isoindolinone p53 Activators
    Valentina Barcherini, Joana B. Loureiro, Ana Sena, Catarina Alexandra Catanas Madeira, Paula Leandro, Lucı́lia Saraiva, Alexandra M. M. Antunes, Maria M. M. Santos · 2023 · Pharmaceuticals
31. Pharmacological inhibition of MDM4 alleviates pulmonary fibrosis
    Qianru Mei, Zhenhua Yang, Zhengkai Xiang, He Zuo, Zijing Zhou, Xiaochuan Dong, Ludan Zhang, Wenhui Song, Yi Wang, Qinghua Hu et al. · 2023 · Theranostics
32. Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells
    Yuta Mitobe, Shuhei Suzuki, Yurika Nakagawa-Saito, Keita Togashi, Asuka Sugai, Yukihiko Sonoda, Chifumi Kitanaka, Masashi Okada · 2023 · Cancers
33. A Re‐examination of the MDM2/p53 Interaction Leads to Revised Design Criteria for Novel Inhibitors
    Natalya I. Vasilevich, Ilya I. Afanasyev, Dmitry A. Kovalskiy, Dmitry V. Genis, Valery S. Kochubey · 2014 · Chemical Biology & Drug Design
34. Role of Wnt-p53-Nox Signaling Pathway in Cancer Development and Progression
    Dhiraj Kumar, Sakshi Sharma, Sagar Verma, Pravir Kumar, Rashmi K. Ambasta · 2015 · Journal of Advances in Medicine and Medical Research
35. Comparison of Burnet's clonal selection theory with tumor cell-clone development
    Borros Michael Arneth · 2018 · Theranostics
36. Specific allelic variants of SNPs in the MDM2 and MDMX genes are associated with earlier tumor onset and progression in Caucasian breast cancer patients
    Marcus Bauer, Eva Johanna Kantelhardt, Thorsten Stiewe, Andrea Nist, Marco Mernberger, Katharina Politt, Volker Hanf, Tilmann Lantzsch, Christoph Uleer, Susanne Peschel et al. · 2019 · Oncotarget
37. A genetic variant within MDM4 3′UTR miRNA binding site is associated with HPV16‐positive tumors and survival of oropharyngeal cancer
    Yang Zhang, Erich M. Sturgis, Peng Wei, Hongliang Liu, Ziqiao Wang, Yiding Ma, Chuan Liu, Kyle J. Gu, Qingyi Wei, Guojun Li · 2019 · Molecular Carcinogenesis
38. MDM2
    David W. Meek · 2014 · Springer eBooks
39. Upregulation of USP25 promotes progression of human diffuse large B-cell lymphoma through blocking the ubiquitinated degradation of MDM2
    Hua Yang, Yanyan Liu, Jingyi Yang, Qing Hua Zhang, Haoran Wang, Yu Chen, Keshu Zhou · 2023 · Biochemical and Biophysical Research Communications
40. Liquid Biopsy Identifies Taxane Resistance and Clonal Selection in Castration-Resistant Prostate Cancer
    Nicole Brighi, Daniel Wetterskog, Osvaldas Vainauskas, Francesco Orlando, Yari Ciani, Giorgia Gurioli, Vincenza Conteduca, Chiara Casadei, Cristian Lolli, Emilio Francesco Giunta et al. · 2025 · Clinical Cancer Research
41. Peptide-Based Targeted Covalent Inhibitors
    Fangyu Cao, Ruo-Chen Guo, Zeyu Zhang, Zhilin Yu · 2025 · ACS Applied Materials & Interfaces
42. The pathogenesis of therapy-related myeloid neoplasms from TP53-mutant clonal hematopoiesis
    Jonas Fullin, Ebru Topçu, Karolina A. Zielińska, Roman R. Schimmer, Nancy Klemm, Christian Koch, Francisco Caiado, Melissa Lock, Cyril Doerdelmann, Marco Matteo Bühler et al. · 2025 · Leukemia
43. LIN28B inhibition sensitizes cells to p53-restoring PPI therapy through unleashed translational suppression
    Jiahao Shi, Xiaoliang Jin, Yihao Wang, Tianyu Zhu, Dongmei Zhang, Qian Li, Xiaomin Zhong, Yaqi Deng, Jianfeng Shen, Xianqun Fan · 2022 · Oncogenesis
44. Synthesis and Antineoplastic Activity of a Dimer, Spiroindolinone Pyrrolidinecarboxamide
    Jingyi Cui, Yujie Wang, Xiaoxin Li, Fei Xiao, Hongjun Ren, Meng Yin Wu · 2023 · Molecules
45. Targeting p53 as a Promising Therapeutic Option for Cancer By Re-Activating the Wt Or Mutant p53’s Tumor Suppression
    Józefa Węsierska‐Gądek · 2018 · Future Medicinal Chemistry
46. Sensitive and simultaneous surface plasmon resonance detection of free and p53-bound MDM2 proteins from human sarcomas
    Ling Wu, Hailin Tang, Shengqiang Hu, Yonghong Xia, Zhixuan Lu, Yujuan Fan, Zixiao Wang, Xinyao Yi, Feimeng Zhou, Jianxiu Wang · 2018 · The Analyst
47. Rigorous Computational and Experimental Investigations on MDM2/MDMX-Targeted Linear and Macrocyclic Peptides
    David Diller, Jon Swanson, Alexander S. Bayden, Chris J. Brown, Dawn Thean, David Philip Lane, Anthony W. Partridge, Tomi K. Sawyer, Joseph Audie · 2019 · Molecules
48. Hyperprogression after immunotherapy: A comprehensive review.
    Muharrem Okan Çakır, Önder Kırca, Seyda Gulenay Gunduz, Mustafa Özdoğan · 2019 · PubMed
49. Leptin Gene Protects Against Cold Stress in Antarctic Toothfish
    Ying Wang, Huamin Wang, Ling-Hong Hu, Liangbiao Chen · 2021 · Frontiers in Physiology
50. Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer
    Meng Yin Wu, Jingyi Cui, Huimin Hou, Ying Li, Shengjie Liu, Li Wan, Lili Zhang, Wei Huang, Gaoyuan Sun, Jingchao Liu et al. · 2022 · Frontiers in Pharmacology
51. Targeted demethylation of the SLC5A7 promotor inhibits colorectal cancer progression
    Yang Li, Baike Liu, Xiaonan Yin, Zhiyuan Jiang, Chao Fang, Na Chen, Bo Zhang, Lei Dai, Yuan Yin · 2022 · Clinical Epigenetics
52. E3 Ubiquitin Ligases: Potential Therapeutic Targets for Skeletal Pathology and Degeneration
    Ruiyin Zeng, Yuan Xiong, Ze Lin, Adriana Christine Panayi, Yun Tian Sun, Faqi Cao, Guohui Liu · 2022 · Stem Cells International
53. Inceptor correlates with markers of prostate cancer progression and modulates insulin/IGF1 signaling and cancer cell migration
    Katharina Wißmiller, Sara Bilekova, András Frankó, Stefan Z. Lutz, Miriam Katsburg, Sebastian Gulde, Natalia Simona Pellegata, Arnulf Stenzl, Martin Heni, Lucia Berti et al. · 2023 · Molecular Metabolism
54. miR ‐3133 inhibits gastrointestinal cancer progression through activation of Hippo and p53 signalling pathways via multi‐targets
    Ling Zhou, Hui Guo, Quan Liao, Jian‐Ping Zou, Yi Le, Ziling Fang, Jianping Xiong, Shanshan Huang, Jun Deng, Xiaojun Xiang · 2023 · Journal of Cellular and Molecular Medicine
55. Allyl-isothiocyanate against colorectal cancer via the mutual dependent regulation of p21 and Nrf2
    Xiaoyan Ren, Gaoshan Zhang, Xiang Ling, Linhua Zhang, Yangyang Tian, Guoxiang Zhu, Pengbo Wang, Jianmei Wu Leavenworth, Lin Luo, Fengzhi Li · 2023 · European Journal of Pharmacology
56. Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution
    Enrico Santinelli, Maria Rosaria Pascale, Zhuoer Xie, Talha Badar, Maximilian F. Stahl, Jan Philipp Bewersdorf, Carmelo Gurnari, Amer Methqal Zeidan · 2023 · Blood Reviews
57. SCYL1BP1 has Tumor-suppressive Functions in Human Lung Squamous Carcinoma Cells by Regulating Degradation of MDM2
    Zhi-Ping Yang, Xie Yong-hong, Dan-yan Ling, Jin-Rui Li, Jin Fang Jiang, Yaohua Fan, Jia-Lian Zheng, Wanxin Wu · 2014 · Asian Pacific Journal of Cancer Prevention
58. The Role of MDM4 SNP34091 A>C Polymorphism in Cancer: A Meta-Analysis on 19,328 Patients and 51,058 Controls
    Xin Jin, Wenchao Zhao, Ming‐Hua Zheng, Peng Zhou, Tianli Niu · 2016 · The International Journal of Biological Markers
59. Mouse double minute 4 variants modify susceptibility to risk of recurrence in patients with squamous cell carcinoma of the oropharynx
    Zhongming Lu, Erich M. Sturgis, Lijun Zhu, Hua Zhang, Ye Tao, Peng Wei, Qingyi Wei, Guojun Li · 2017 · Molecular Carcinogenesis
60. Systemic network analysis identifies XIAP and IκBα as potential drug targets in TRAIL resistant BRAF mutated melanoma
    Greta Del Mistro, Philippe Lucarelli, Ines Müller, Sébastien De Landtsheer, Anna Zinoveva, Meike Hutt, Martin Siegemund, Roland E. Kontermann, Stefan Beissert, Thomas Sauter et al. · 2018 · npj Systems Biology and Applications
61. MDM2/P53 Inhibitors as Sensitizing Agents for Cancer Chemotherapy
    Yan Yu Zhu, Herui Wang, Asha Thuraisamy · 2019 · Elsevier eBooks
62. Oscillatory Dynamics of p53-Mdm2 Circuit in Response to DNA Damage Caused by Ionizing Radiation
    Yuan Zhang, Haihong Liu, Zhouhong Li, Zhonghua Miao, Jin Zhou · 2019 · IEEE Transactions on Computational Biology and Bioinformatics
63. A New Way to Target p53-Defective Colorectal Cancer
    Yunhua Liu, Liana Wang, Xiongbin Lu · 2015 · Future Oncology
64. TP53 mutations and drug sensitivity in acute myeloid leukaemia cells with acquired MDM2 inhibitor resistance
    Martin Michaelis, Constanze Schneider, Florian Rothweiler, Tamara Rothenburger, Marco Mernberger, Andrea Nist, Andreas von Deimling, Daniel Speidel, Thorsten Stiewe, Jindrich Jr. Cinatl · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
65. Rational design, synthesis, and biophysical characterization of a peptidic MDM2-MDM4 interaction inhibitor
    Marco Ballarotto, Elisa Bianconi, Sonia Valentini, Andrea Temperini, Fabiola Moretti, Antonio Macchiarulo · 2024 · Bioorganic & Medicinal Chemistry
66. Gut microbes and their metabolites in relation to the classic tumor suppressor gene P53: a novel narrative
    Jia-Xuan Li, Chenguang Liu, Jun Chen · 2025 · npj Biofilms and Microbiomes
67. Nucleosomes specify co-factor access to p53
    Deyasini Chakraborty, Colby R. Sandate, Luke Isbel, Georg Kempf, Joscha Weiss, Simone Cavadini, Lukas Kater, Jan Seebacher, Zuzanna Kozicka, Lisa Stoos et al. · 2025 · Molecular Cell
68. The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells
    Johanna Huun, Liv B. Gansmo, Bård Mannsåker, Gjertrud T. Iversen, Jan Knudtzon Sommerfelt-Pettersen, Jan Inge Øvrebø, Per Eystein Lønning, Stian Knappskog · 2017 · Translational Oncology
69. MDMX elevation by a novel Mdmx–p53 interaction inhibitor mitigates neuronal damage after ischemic stroke
    Haomin Yan, Tsutomu Sasaki, Hideaki Kanki, Yoshiyuki Hirata, Kumiko Nishiyama, Sunao Hisada, Shigenobu Matsumura, Yasuo Nagaoka, Takaaki Sumiyoshi, Seiichi Nagano et al. · 2022 · Scientific Reports
70. miR-34c-5p inhibited fibroblast proliferation, differentiation and epithelial-mesenchymal transition in benign airway stenosis via MDMX/p53 pathway
    Jinmei Wei, Yan Chen, Tingmei Feng, Yuihui Wei, CaiZhen Yang, Changwen Zhang, Wentao Li, Guangnan Liu · 2024 · Functional & Integrative Genomics
71. Synthesis and biological evaluation of 4-imidazolidinone–containing compounds as potent inhibitors of the MDM2/p53 interaction
    Zhitong Lin, Chen Liu, Ziqin Yan, Jing Cheng, Xiancheng Wang, Feilong Zhou, Xilin Lyu, Shiyan Zhang, Daizhou Zhang, Xiangjing Meng et al. · 2024 · European Journal of Medicinal Chemistry
72. Revealing binding selectivity of ligands toward murine double minute 2 and murine double minute X based on molecular dynamics simulations and binding free energy calculations
    Shuhua Shi, Kai Sui, Weizhe Liu, Yanzi Lei, Shaolong Zhang, Qinggang Zhang · 2019 · Journal of Biomolecular Structure and Dynamics
73. MDMX/MDM4 is highly expressed and contributes to cell growth and survival in anaplastic large cell lymphoma
    Vaios Sinatkas, Κωνσταντίνα Σταθοπούλου, Ioanna Xagoraris, Jingjing Ye, Dimitra Vyrla, Vassilios Atsaves, Vasiliki Leventaki, Leonard Jeffrey Medeiros, George Z. Rassidakis, Elias Drakos · 2021 · Leukemia & lymphoma/Leukemia and lymphoma
74. Recent insight into the role of RING-finger E3 ligases in glioma
    Yang Cao, Hang Zhou, Xiaoyu Chen, Yin Li, Junwen Hu, Guoyang Zhou, Lin Wang · 2021 · Biochemical Society Transactions
75. Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma
    Si Yang, Bowen Yao, Liming Wu, Yuanxing Liu, Kang Liu, Peng Xu, Yi Zheng, Yujiao Deng, Zhen Zhai, Ying Wu et al. · 2021 · Molecular Therapy — Oncolytics
76. miR-34a-5p enhances the sensitivity of cervical cancer cells to oxaliplatin chemotherapy via targeting MDM4
    Pei Ting He, Xiaoli Liu, Yanqin Lou, Shixiong Gong, Lirong Cao · 2022 · Clinical and Experimental Obstetrics & Gynecology
77. CEACAM5 inhibits the lymphatic metastasis of head and neck squamous cell carcinoma by regulating epithelial–mesenchymal transition via inhibiting MDM2
    Xudong Wang, Yanshi Li, Min Pan, Tao Lu, Min Wang, Zhihai Wang, Chuan Liu, Guohua Hu · 2022 · Clinical Science
78. FAM193A is a positive regulator of p53 activity
    Maria M. Szwarc, Anna L. Guarnieri, Molishree Joshi, Huy Nguyen Duc, Madison C. Laird, Ahwan Pandey, Santosh Khanal, Emily Dohm, Aimee K. Bui, Kelly D. Sullivan et al. · 2023 · Cell Reports
79. Computational-based drug design of novel small molecules targeting p53-MDMX interaction
    Abel Ujaigbe Egbemhenghe, Olajide Enoch Aderemi, Bamidele Samson Omotara, Faith Iyayi Akhimien, Faith Osaretin Osabuohien, Habeebulah Ajibola Adedapo, Oluwakemi Rita Temionu, Winner Amaka Egejuru, Chinedum Favour Ajala, Meejay Francis Ihunanya et al. · 2023 · Journal of Biomolecular Structure and Dynamics
80. Kinesin superfamily member 15 knockdown inhibits cell proliferation, migration, and invasion in nasopharyngeal carcinoma
    Yi Cai, Qianyue Lai, Xuan Zhang, Yu Zhang, Man Zhang, Shaoju Gu, Yuan Qin, Jingshen Hou, Li Zhao · 2023 · Korean Journal of Physiology and Pharmacology
81. High-capacity sample multiplexing for single cell chromatin accessibility profiling
    Gregory T. Booth, Riza M. Daza, Sanjay R Srivatsan, José L. McFaline‐Figueroa, Rula Green Gladden, Andrew C. Mullen, Scott N. Furlan, Jay Shendure, Cole Trapnell · 2023 · BMC Genomics
82. Exploring 2-(benzylthio)-5-(4-nitrophenyl)-1,3,4-oxadiazole as antiproliferative agent: Synthesis, single crystal XRD, DFT, Hirshfeld surface analysis, in vitro antiproliferative activity and molecular docking analysis
    Riya Kumari, Shivendra Kumar Pandey, Abhay Kumar Patel, Divya Kushwaha, Arbind Acharya, M.K. Bharty · 2024 · Journal of Molecular Structure
83. Lack of association betweenMDM2promoter SNP309 and clinical outcome in patients with neuroblastoma
    Ali Rihani, Tom Van Maerken, Bram De Wilde, Fjoralba Zeka, Geneviève Laureys, Koen Norga, Gian Paolo Tonini, Simona Coco, Rogier Versteeg, Rosa Noguera et al. · 2014 · Pediatric Blood & Cancer
84. Native PAGE to study the interaction between the oncosuppressor p53 and its protein ligands
    Anna Lamberti, Roberta Sgammato, Doriana Desiderio, Chiara Punzo, Gennaro Raimo, Ettore Novellino, Alfonso Carotenuto, Mariorosario Masullo · 2014 · Electrophoresis
85. MDM2 oncogene, E3 ubiquitin protein ligase T309G polymorphism and risk of oesophageal or gastric cancer: Meta-analysis of 15 studies
    Wei Shen, Ping Hu, Jiaqing Cao, Xiuxia Liu, Jianghua Shao · 2014 · Journal of International Medical Research
86. Relationship Between Murine Double Minute 2 (MDM2) T309G Polymorphism and Endometrial Cancer Risk: A Meta-Analysis
    Zhuowei Xue, Xiaolu Zhu, Yincheng Teng · 2016 · Medical Science Monitor
87. Studies of ATM Kinase Activity Using Engineered ATM Sensitive to ATP Analogues (ATM-AS)
    Masato Enari, Yuko Matsushima‐Hibiya, Makoto Miyazaki, Ryo Otomo · 2017 · Methods in molecular biology
88. Drosophila SCE/dRING E3-ligase inhibits apoptosis in a Dp53 dependent manner
    Carolina J Simoes da Silva, Sol Fereres, Rocío Simón, Ana Busturia · 2017 · Developmental Biology
89. Studying Homo-oligomerization and Hetero-oligomerization of MDMX and MDM2 Proteins in Single Living Cells by Using In Situ Fluorescence Correlation Spectroscopy
    Fucai Li, Shengrong Yu, Xiangyi Huang, Chaoqing Dong, Jicun Ren · 2021 · Biochemistry
90. Effect of the Flexible Regions of the Oncoprotein Mouse Double Minute X on Inhibitor Binding Affinity
    Lingyun Qin, Huili Liu, Rong Chen, Jingjing Zhou, Xiyao Cheng, Yao Chen, Yongqi Huang, Zhengding Su · 2017 · Biochemistry
91. Recent Applications of Multicomponent Reactions Toward Heterocyclic Drug Discovery
    Nathan Bedard, Alessandra Fistrovich, Kevin Schofield, Arthur Y. Shaw, Christopher Hulme · 2021 · Wiley eBooks
92. Function of p53 in angiogenesis and oxidative stress in rheumatoid arthritis
    Behrouz Robat-Jazi, Elham Farhadi, Mahdi Mahmoudi, Ahmadreza Jamshidi, Maassoumeh Akhlaghi, Arash Sharafat Vaziri · 2025 · Clinical and Experimental Medicine
93. The need for speed: drivers and consequences of accelerated replication forks
    Dávid Lukáč, Katarína Chromá, Pavel Moudrý · 2025 · Communications Biology
94. Targeting mutant p53 in cancer: from mechanistic insights to therapeutic strategies
    H. Helena Wu, Sarah Leng, David D. Eisenstat, Consolato Maria Sergi, Roger P. Leng · 2026 · Cellular & Molecular Biology Letters
95. Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells
    Rati Lama, Samuel L. Galster, Chao Xu, Luke W. Davison, Sherry R. Chemler, Xinjiang Wang · 2022 · Molecules
96. 18 F-FDG PET/CT Predicts the Prognosis of Patients with Hepatocellular Carcinoma Undergoing Liver Transplantation
    Wen-Jing Zheng, Yang Xu, Hui Shan Tan, Shuguang Chen, Pengxiang Wang, Haixiang Sun, Rui‐Zhe Li, Haiying Zeng, Yu-Chen Zhong, Jianwen Cheng et al. · 2025 · Liver Cancer
97. Modeling human brain rhabdoid tumor by inactivating tumor suppressor genes in induced pluripotent stem cells
    Timothy Hua, Yu Xue, Drishty Badhon Sarker, Sonia Kiran, Yan Li, Qing‐Xiang Amy Sang · 2023 · Bioactive Materials
98. Three-Dimensional Gene Regulation Network in Glioblastoma Ferroptosis
    Man Liu, Wenbin Wang, Han Zhang, Jinfang Bi, Baoying Zhang, Tengfei Shi, Guangsong Su, Yaoqiang Zheng, Sibo Fan, Xiaofeng Huang et al. · 2023 · International Journal of Molecular Sciences
99. Linc‐ROR inhibits NK cell‐killing activity by promoting RXRA ubiquitination and reducing MICB expression in gastric cancer patients
    Qingbin Niu, Zongrui Li, Jiang He, Baoguang Hu · 2024 · Journal of Cellular Biochemistry
100. Targeting the ubiquitin-proteasome system: a novel therapeutic strategy for neuroblastoma
     Yangshen He, Jianing Wang, Tiantian Xiao · 2024 · Frontiers in Oncology